A Frenzy of Lobbying on 21st Century Cures

Kaiser Health News, November 28, 2016. Beyond the pharmaceutical industry, the bill’s supporters include universities, medical schools and groups representing them, as well as patient groups funded by drug and device companies. “It really is a David and Goliath issue of where the money is,” NCHR president Diana Zuckerman said.

Read More »

This Tiny Plastic Implant May Disrupt America’s Opioid Addiction Problem

Motherboard by Vice, November 15, 2016. “I think the big issue is the transition,” said Diana Zuckerman, NCHR President, who was not involved with the trials. “People are going to go from taking pills to using this implant. The implant doesn’t work immediately. It takes a while for it to work and settle into the level that it’s supposed to be. And during that time the person is still going to be taking pills, and that becomes a vulnerable time. How many pills should that person take before the implant is really working, and should they continue to take pills after it’s working?“

Read More »